Trial intelligence / Profile preview

KBMSI-2 in Erectile Dysfunction

NCT02413099Phase 4Completed

Start
Feb 2012
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of KBMSI-2 in erectile dysfunction (ED). Started Feb 2012; status: completed.

02

Drugs

KBMSI-2
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT02413099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02413099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call